javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.09434338091780.5093
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.69873811568496.8379
Domestic EquitiesCipla Ltd.7.44833430942480.6750
Domestic EquitiesMankind Pharma Ltd.7.02931909575453.6386
Domestic EquitiesDivi's Laboratories Ltd.6.0638586962391.3276
Domestic EquitiesBiocon Ltd.4.71477098250304.2665
Domestic EquitiesCohance Lifesciences Ltd.4.37216538941282.1553
Domestic EquitiesAlkem Laboratories Ltd.4.0821479158263.4411
Domestic EquitiesMedplus Health Services Ltd3.85922782070249.0509
Domestic EquitiesMAX Healthcare Institute Ltd3.36482250000217.1475
Domestic EquitiesLupin Ltd.3.0569869954197.2795
Domestic EquitiesSyngene International Ltd.2.98644360323192.7263
Domestic EquitiesThyrocare Technologies Ltd.2.39503052801154.5633
Domestic EquitiesAbbott India Ltd.2.137751371137.9568
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.2.00512467084129.3986
Domestic EquitiesPfizer Ltd.1.9768277423127.5730
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.9436578725125.4329
Domestic EquitiesAurobindo Pharma Ltd.1.9238870394124.1530
Domestic EquitiesAlivus Life Sciences Ltd.1.76711080414114.0377
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.75811541322113.4567
Domestic EquitiesEntero Healthcare Solutions1.7426940428112.4564
Domestic EquitiesMetropolis Healthcare Ltd.1.5354178421099.0861
Domestic EquitiesRainbow Childrens Medicare Ltd1.441167376092.9991
Domestic EquitiesBlue Jet Healthcare Ltd.1.3983200818890.2379
Domestic EquitiesMedi Assist Healthcare Services Ltd1.3752240773988.7493
Domestic EquitiesHikal Ltd.1.2104400009478.1138
Domestic EquitiesFine Organic Industries Ltd.1.190916616276.8566
Domestic EquitiesAarti Drugs Ltd.1.0996186543270.9610
Domestic EquitiesSanofi Consumer Healthcare India Ltd1.023614396066.0560
Domestic EquitiesWindlas Biotech Ltd.0.955974046361.6880
Domestic EquitiesLaxmi Dental Ltd.0.7956220785951.3438
Domestic EquitiesAstrazeneca Pharma India Ltd.0.77955828250.3061
Domestic EquitiesFDC Ltd.0.7687122492049.6093
Domestic EquitiesShilpa Medicare Ltd.0.713292245646.0259
Domestic EquitiesIndoco Remedies Ltd.0.4703144755330.3494
Domestic EquitiesJupiter Life Line Hospitals Ltd0.392919105825.3553
Domestic EquitiesAnthem Biosciences Ltd0.247120982015.9453
Total 99.8179 6441.7668
Cash & Cash Equivalents and Net AssetsTREPS5.1785 334.1974
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.0063 0.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-5.0027 -322.8529
Total 0.1821 11.7497
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.